Tag Archives: Patients

FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Print this page NEWTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved oral Xpovio (selinexor), a nuclear export inhibitor, in combination… Read More »

ONC: Patients must balance benefits of third-party apps with risks

While the Office of the National Coordinator for Health IT is pushing to empower patients to access and share their electronic health information, ONC is warning about the inherent risks from third-party apps. In March, ONC issued a proposed rule requiring healthcare providers to offer patients’ access to their electronic health information through secure, standards-based… Read More »